KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Other Accumulated Expenses (2011 - 2014)

Stereotaxis (STXS) reported Other Accumulated Expenses of $300524.0 for Q3 2014, down 75.89% year-over-year from $1.2 million in Q3 2013, and down 11.14% on a QoQ basis from $338181.0 in Q2 2014.

Stereotaxis (STXS) has 4 years of Other Accumulated Expenses data on file, last reported at $300524.0 in Q3 2014.

  • Quarterly Other Accumulated Expenses fell 75.89% year-over-year to $300524.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $300524.0 (down 75.89% YoY) and the FY2013 annual result came in at $351925.0, down 21.93% from the prior year.
  • Other Accumulated Expenses fell to $300524.0 in Q3 2014 per STXS's latest filing, from $338181.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.9 million in Q2 2012 and bottomed at $300524.0 in Q3 2014.
  • The 4-year median for Other Accumulated Expenses is $869769.0 (2013), against an average of $1.2 million.
  • The widest annual swing landed in 2012, when Other Accumulated Expenses sank 81.39%; it then soared 111.69% in 2014.
  • Tracing STXS's Other Accumulated Expenses over 4 years: stood at $2.4 million in 2011, then slumped by 81.39% to $450777.0 in 2012, then slipped by 21.93% to $351925.0 in 2013, then fell by 14.61% to $300524.0 in 2014.
  • Per Business Quant, the three latest STXS Other Accumulated Expenses figures stand at $300524.0 (Q3 2014), $338181.0 (Q2 2014), and $1.3 million (Q1 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2014 300,524.00
Jun 30, 2014 338,181.00
Mar 31, 2014 1.26 Mn
Dec 31, 2013 351,925.00
Sep 30, 2013 1.25 Mn
Jun 30, 2013 869,769.00
Mar 31, 2013 596,920.00
Dec 31, 2012 450,777.00
Sep 30, 2012 2.81 Mn
Jun 30, 2012 2.90 Mn
Dec 31, 2011 2.42 Mn